FDA Approves Pharming's Immune Disorder Drug

The US Food and Drug Administration on Friday approved Pharming Group's drug to treat a rare genetic disorder that leads to a weakened immune system, the Dutch company said.
Reuters Health Information

source https://www.medscape.com/viewarticle/990117?src=rss

Comments

Popular posts from this blog

DC’s Harllee Harper Is Using Public Health Tools to Prevent Gun Violence. Will It Work?